Evidence map›Paper›PMID 27703127›Full record

ArticleEpidemiology and health2016

Age-period-cohort analysis of hepatitis A incidence rates in Korea from 2002 to 2012.

Joo Yeon Seo, Sungyong Choi, BoYoul Choi, Moran Ki

Abstract read
In one paragraph

Article in Epidemiology and health, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Hepatitis A vaccination.Human vaccines & immunotherapeutics · 2020
    Article
  2. Article
  3. Article
  4. Viral Hepatitis in South Korea.Euroasian journal of hepato-gastroenterology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Joo Yeon SeoDepartment of Preventive Medicine & Institute for Health and Society, Hanyang University College of Medicine, Seoul, Korea.
Sungyong ChoiGyeonggi Infectious Disease Control Center, Seongnam, Korea.
BoYoul ChoiDepartment of Preventive Medicine & Institute for Health and Society, Hanyang University College of Medicine, Seoul, Korea.
Moran KiDepartment of Cancer Control and Policy, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study aimed to evaluate the epidemiology of hepatitis A in Korea from 2002 to 2012 using age-period-cohort analyses.

methodsWe used claims data from the Korean National Health Insurance Corporation for the entire population. Census data from 2010 were used as the standard population. The incidence of hepatitis A was assumed to have a Poisson distribution, and the models and effects were evaluated using the intrinsic estimator method, the likelihood ratio, and the Akaike information criterion.

resultsThe incidence of hepatitis A gradually increased until 2007 (from 17.55 to 35.72 per 100,000 population) and peaked in 2009 (177.47 per 100,000 population). The highest incidence was observed among 27-29-year-old individuals when we omitted data from 2005 to 2007. From 2005 to 2007, the peak incidence was observed among 24-26-year-old individuals, followed by 27-29-year-olds. The best model fits were observed when the age-period-cohort variables were all considered at the same time for males, females, and the whole population.

conclusionsThe incidence of hepatitis A exhibited significant age-period-cohort effects; its incidence peaked in 2009 and was especially high among Koreans 20-39 years of age. These epidemiological patterns may help predict when high incidence rates of hepatitis A may occur in developing countries during their socioeconomic development.

Indexed as

Developing CountriesSanitationAdolescentAdultAgedAged, 80 and overAge FactorsChildChild, PreschoolCohort StudiesDatabases, FactualEconomic DevelopmentFemaleHepatitis AHumansIncidenceEpidemiologyHepatitis AIncidence

Identifiers

PMID27703127
PMCPMC5114437

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.